针对初级中枢神经系统淋巴瘤的新疗法
Elisa Aquilanti1, Elizabeth Herrity2, Lakshmi Nayak3
1Center for Neuro Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
Current neurology and neuroscience reports
|October 10, 2024
概括
针对初级中枢神经系统淋巴瘤 (PCNSL) 正在出现新型疗法,为复发性或耐药性疾病患者提供新的希望. 本综述强调了针对性药物和免疫疗法,以解决关键的瘤原因驱动因素.
科学领域:
- 神经瘤学神经瘤学
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 初级中枢神经系统淋巴瘤 (PCNSL) 是一种具有恶性恶性瘤,预后不佳,复发/耐药病例的治疗选择有限.
- 目前PCNSL的5年生存率仍然很低,这强调了需要创新的治疗策略.
研究的目的:
- 审查支持PCNSL新型治疗剂的证据.
- 讨论正在进行的临床研究,研究PCNSL的新疗法.
- 探索驱动PCNSL的病原和瘤性途径.
主要方法:
- 关于PCNSL病原和新疗法的最新研究的文献综述.
- 对新兴治疗方法的临床试验数据的分析.
- 针对性治疗和免疫治疗的讨论.
主要成果:
- 在PCNSL中,关键的瘤驱动因素包括NFkB通路激活,细胞循环失调,体质突变和免疫逃避.
- 研究中的疗法包括BTK抑制剂,mTOR/PI3K抑制剂,免疫调节剂 (IMID),免疫检查点抑制剂和基于CD19的CAR T细胞.
- 对于PCNSL的治疗场景正在迅速发展.
结论:
- 新型向和免疫疗法在PCNSL治疗方面显示出前景.
- 结合化疗与新药的多模式治疗方法可能是PCNSL治疗的未来.
- 进一步的临床研究对于确定这些新兴疗法的疗效至关重要.
相关概念视频
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)